📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex. (2019)

First Author: Schmidt L

Attributed to: Cellular mechanisms of haematopoietic lineage commitment funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41375-019-0382-3

PubMed Identifier: 30679799

Publication URI: http://europepmc.org/abstract/MED/30679799

Type: Journal Article/Review

Volume: 33

Parent Publication: Leukemia

Issue: 7

ISSN: 0887-6924